
Alexandria
Description
Alexandria Venture Investments is the dedicated strategic venture capital arm of Alexandria Real Estate Equities, Inc. (NYSE: ARE), a leading real estate investment trust focused on collaborative life science, agrifoodtech, and technology campuses. Established in 1996, Alexandria Venture Investments leverages its parent company's deep industry expertise and extensive network to identify and support groundbreaking companies across various stages, from seed to late-stage. Their investment strategy is highly synergistic, aiming to foster innovation within the sectors where Alexandria Real Estate Equities operates, often providing portfolio companies with access to state-of-the-art laboratory and office space, as well as strategic partnerships and resources.
The firm's unique value proposition extends beyond capital, offering a comprehensive ecosystem designed to accelerate the growth and success of its portfolio companies. This includes facilitating connections with key opinion leaders, potential collaborators, and strategic partners within the life science and technology communities. Alexandria Venture Investments is committed to building long-term relationships, acting as a supportive partner throughout a company's lifecycle, from initial concept to commercialization and beyond.
Alexandria Venture Investments boasts a substantial and diverse portfolio, reflecting its long-standing commitment to critical innovation sectors. As of December 31, 2023, the firm had invested in over 700 companies, demonstrating a broad reach across the innovation landscape. Their total portfolio investments amounted to approximately $2.6 billion, underscoring their significant financial commitment to fostering scientific and technological advancements. This extensive track record positions Alexandria Venture Investments as a pivotal player in the venture capital ecosystem, particularly for companies seeking not just funding, but also strategic real estate solutions and a robust support network.
Investor Profile
Alexandria has backed more than 41 startups, with 0 new investments in the last 12 months alone. The firm has led 1 rounds, about 2% of its total and boasts 20 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series A, Series B, Series C rounds (top funding stages).
- Majority of deals are located in United States, France.
- Strong thematic focus on Biotechnology, Health Care, Therapeutics.
- Typical check size: $1M – $25M.
Stage Focus
- Series A (39%)
- Series B (37%)
- Series C (12%)
- Seed (5%)
- Convertible Note (2%)
- Private Equity (2%)
- Series Unknown (2%)
Country Focus
- United States (98%)
- France (2%)
Industry Focus
- Biotechnology
- Health Care
- Therapeutics
- Life Science
- Pharmaceutical
- Medical
- Genetics
- Biopharma
- Artificial Intelligence (Ai)
- Agtech
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.